Impact of the new clinical breaking points proposed by the clinical and laboratory standards institute (CLSI) in the antifungal susceptibility profile of clinical strains isolated from invasive bloodstream Candida spp. infections in Spain

1. Cisterna, R.
2. Tellería, O.
3. Hernaez, S.
4. Ezpeleta, G.

Exportar

Exportar

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Exportar

×

El documento no se puede exportar porque pertenece a otro portal.

Texto completo

lock_openTexto completo externo

DOI: 10.4137/CMT.S8293 GOOGLE SCHOLAR lock_openAcceso abierto editor

Fuente de los datos: Scopus